Targeting aPKC disables oncogenic signaling by both the EGFR and the proinflammatory cytokine TNFa in glioblastoma | ||
| dc.conicet.organizacion | Arizona State University | |
| dc.conicet.organizacion | University of Yale. School of Medicine | |
| dc.conicet.organizacion | Banner MD Anderson Cancer Center | |
| dc.conicet.organizacion | Armed Forces Institute of Pathology | |
| dc.conicet.organizacion | University of Yale | |
| dc.conicet.organizacion | University of Arizona | |
| dc.conicet.organizacion | University of Yale. School of Medicine | |
| dc.conicet.organizacion | Universidad de Buenos Aires. Facultad de Medicina. Cátedra de Farmacología | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay | |
| dc.conicet.organizacion | University of California | |
| dc.conicet.organizacion | Translational Genomics Research Institute | |
| dc.conicet.organizacion | Mayo Clinic Cancer Center | |
| dc.conicet.organizacion | University of Arizona | |
| dc.conicet.organizacion | University of Texas Health Science Center at Houston. University of Texas Md Anderson Cancer Center | |
| dc.conicet.organizacion | University of Texas Health Science Center at Houston. University of Texas Md Anderson Cancer Center | |
| dc.conicet.organizacion | University of Texas Health Science Center at Houston. University of Texas Md Anderson Cancer Center | |
| dc.conicet.organizacion | Arizona State University | |
| dc.conicet.organizacion | University of Yale. School of Medicine | |
| dc.conicet.organizacion | Arizona State University | |
| dc.conicet.organizacion | University of Yale. School of Medicine | |
| dc.contributor.author | Yael, Kusne | |
| dc.contributor.author | Carrera Silva, Eugenio Antonio | |
| dc.contributor.author | Perry, Anthony S. | |
| dc.contributor.author | Rushing, Elisabeth J. | |
| dc.contributor.author | Mandell, Edward K. | |
| dc.contributor.author | Dietrich, Justin D. | |
| dc.contributor.author | Errasti, Andrea Emilse | |
| dc.contributor.author | Gibbs, Daniel | |
| dc.contributor.author | Berens, Michael E. | |
| dc.contributor.author | Loftus, Joseph C. | |
| dc.contributor.author | Hulme, Christopher | |
| dc.contributor.author | Yang, Weiwei | |
| dc.contributor.author | Lu, Zhimin | |
| dc.contributor.author | Aldape, Kenneth | |
| dc.contributor.author | Sanai, Nader | |
| dc.contributor.author | Rothlin, Carla V. | |
| dc.contributor.author | Ghosh, Sourav | |
| dc.date.issued | 2014-08 | |
| dc.description.abstract | Grade IV glioblastoma is characterized by increased kinase activity of epidermal growth factor receptor (EGFR); however, EGFR kinase inhibitors have failed to improve survival in individuals with this cancer because resistance to these drugs often develops. We showed that tumor necrosis factor-alpha (TNFa) produced in the glioblastoma microenvironment activated atypical protein kinase C (aPKC), thereby producing resistance to EGFR kinase inhibitors. Additionally, we identified that aPKC was required both for paracrine TNFa-dependent activation of the transcription factor nuclear factor kappa B (NF-kB) and for tumor cell-intrinsic receptor tyrosine kinase signaling. Targeting aPKC decreased tumor growth in mouse models of glioblastoma, including models of EGFR kinase inhibitor-resistant glioblastoma. Furthermore, aPKC abundance and activity were increased in human glioblastoma tumor cells, and high aPKC abundance correlated with poor prognosis. Thus, targeting aPKC might provide an improved molecular approach for glioblastoma therapy. | es |
| dc.description.fil | Fil: Yael, Kusne. Arizona State University; Estados Unidos | |
| dc.description.fil | Fil: Carrera Silva, Eugenio Antonio. University of Yale. School of Medicine; Estados Unidos | |
| dc.description.fil | Fil: Perry, Anthony S.. Banner MD Anderson Cancer Center; Estados Unidos | |
| dc.description.fil | Fil: Rushing, Elisabeth J.. Armed Forces Institute of Pathology; Estados Unidos | |
| dc.description.fil | Fil: Mandell, Edward K.. University of Yale; Estados Unidos | |
| dc.description.fil | Fil: Dietrich, Justin D.. University of Arizona; Estados Unidos | |
| dc.description.fil | Fil: Errasti, Andrea Emilse. University of Yale. School of Medicine; Estados Unidos. Universidad de Buenos Aires. Facultad de Medicina. Cátedra de Farmacología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina | |
| dc.description.fil | Fil: Gibbs, Daniel. University of California; Estados Unidos | |
| dc.description.fil | Fil: Berens, Michael E.. Translational Genomics Research Institute; Estados Unidos | |
| dc.description.fil | Fil: Loftus, Joseph C.. Mayo Clinic Cancer Center; Estados Unidos | |
| dc.description.fil | Fil: Hulme, Christopher. University of Arizona; Estados Unidos | |
| dc.description.fil | Fil: Yang, Weiwei. University of Texas Health Science Center at Houston. University of Texas Md Anderson Cancer Center; Estados Unidos | |
| dc.description.fil | Fil: Lu, Zhimin. University of Texas Health Science Center at Houston. University of Texas Md Anderson Cancer Center; Estados Unidos | |
| dc.description.fil | Fil: Aldape, Kenneth. University of Texas Health Science Center at Houston. University of Texas Md Anderson Cancer Center; Estados Unidos | |
| dc.description.fil | Fil: Sanai, Nader. Arizona State University; Estados Unidos | |
| dc.description.fil | Fil: Rothlin, Carla V.. University of Yale. School of Medicine; Estados Unidos | |
| dc.description.fil | Fil: Ghosh, Sourav. Arizona State University; Estados Unidos. University of Yale. School of Medicine; Estados Unidos | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Yael, Kusne; Carrera Silva, Eugenio Antonio; Perry, Anthony S.; Rushing, Elisabeth J.; Mandell, Edward K.; et al.; Targeting aPKC disables oncogenic signaling by both the EGFR and the proinflammatory cytokine TNFa in glioblastoma; American Association for the Advancement of Science; Science Signaling; 7; 338; 8-2014; ra75-ra75 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 1937-9145 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/112908 | |
| dc.journal.number | 338 | es |
| dc.journal.pagination | ra75-ra75 | es |
| dc.journal.pais | Estados Unidos | es |
| dc.journal.title | Science Signaling | es |
| dc.journal.volume | 7 | es |
| dc.language.iso | eng | es |
| dc.publisher | American Association for the Advancement of Science | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486020/ | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/https://dx.doi.org/10.1126%2Fscisignal.2005196 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | aPKC | es |
| dc.subject | EGFR | es |
| dc.subject | TNFα | es |
| dc.subject | glioblastoma | es |
| dc.subject.classification | Patología | es |
| dc.subject.classification | Medicina Básica | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Targeting aPKC disables oncogenic signaling by both the EGFR and the proinflammatory cytokine TNFa in glioblastoma | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.fa99a25a-2746-4a38-bc86-1542553a147c_s.pdf
- Tamaño:
- 1.27 MB
- Formato:
- Adobe Portable Document Format
- Descripción: